英國監管機構批準波音(BA.US)47億美元收購Spirit(SPR.US)交易
英國反壟斷監管機構初步調查後,批準波音公司(BA.US)以47億美元收購Spirit AeroSystems(SPR.US)的合併交易。
英國競爭與市場管理局(CMA)週五宣佈,決定不就該交易更深入調查,但暫未公佈批準原因。
波音去年7月同意以每股37.25美元的全股票交易回購Spirit,交易估值爲47億美元,連同Spirit的淨負債,交易總值達83億美元。Spirit發言人表示,交易正按計劃進行,預計將於今年第四季度完成。
交易完成後,令兩間公司在分拆20年後再度合併,Spirit爲波音737、787夢幻客機及其他民用飛機的重要供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.